Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

Cristina Muniesa; Eva Domingo-Domenech; Rosa Fornons-Servent; Yeray Peñate; M Teresa Estrach; M Dolores Ramón; Susana Medina; Ángeles Flórez; Pablo L Ortiz-Romero; M Prado Sánchez-Caminero; Ignacio Torres-Navarro; Elvira Acebo; Ignacio Yanguas; Ricardo Fernández-de-Misa; Mar Blanes; Ana Zayas; Miguel A Descalzo; Ignacio Garcia-Doval; Octavio Servitje

doi:10.1016/j.jaad.2020.07.028

Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

J Am Acad Dermatol. 2020 Nov;83(5):1535-1538. doi: 10.1016/j.jaad.2020.07.028. Epub 2020 Jul 16.

Authors

Cristina Muniesa¹, Eva Domingo-Domenech², Rosa Fornons-Servent³, Yeray Peñate⁴, M Teresa Estrach⁵, M Dolores Ramón⁶, Susana Medina⁷, Ángeles Flórez⁸, Pablo L Ortiz-Romero⁹, M Prado Sánchez-Caminero¹⁰, Ignacio Torres-Navarro¹¹, Elvira Acebo¹², Ignacio Yanguas¹³, Ricardo Fernández-de-Misa¹⁴, Mar Blanes¹⁵, Ana Zayas¹⁶, Miguel A Descalzo¹⁷, Ignacio Garcia-Doval¹⁷, Octavio Servitje¹⁸

Affiliations

¹ Department of Dermatology, Hospital Universitari de Bellvitge, Universitat de Barcelona, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Dermatology, Hospital de Viladecans, Viladecans, Barcelona, Spain.
² Derpartment of Hematology, Institut Català d'Oncologia, Hospital Duran i Reynals, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de LLobregat, Barcelona, Spain.
³ Department of Dermatology, Hospital Universitari de Bellvitge, Universitat de Barcelona, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
⁴ Department of Dermatology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Las Palmas, Spain.
⁵ Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.
⁶ Department of Dermatology, Hospital Clínico Universitario de Valencia, Valencia, Spain.
⁷ Department of Dermatology, Hospital de Alcalá de Henares, Madrid, Spain.
⁸ Department of Dermatology, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
⁹ Department of Dermatology, Hospital 12 de Octubre, Institute I+12 Research Institute, Universidad Complutense, Madrid, Spain.
¹⁰ Department of Dermatology, Hospital General Universitario, Ciudad Real, Spain.
¹¹ Department of Dermatology, Hospital Universitario La Fe, Valencia, Spain.
¹² Department of Dermatology, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain.
¹³ Department of Dermatology, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.
¹⁴ Department of Dermatology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
¹⁵ Department of Dermatology, Hospital General Universitario, Alicante, Spain.
¹⁶ Department of Dermatology, Hospital Universitario Dr Peset, Valencia, Spain.
¹⁷ Research Unit, Fundación Piel Sana Academia Española de Dermatología, Madrid, Spain.
¹⁸ Department of Dermatology, Hospital Universitari de Bellvitge, Universitat de Barcelona, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: [email protected].

PMID: 32682893
DOI: 10.1016/j.jaad.2020.07.028

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Agents, Immunological / administration & dosage*
Female
Humans
Infusions, Intravenous
Lymphoma, B-Cell / drug therapy*
Male
Middle Aged
Prospective Studies
Registries
Rituximab / administration & dosage*
Skin Neoplasms / drug therapy*
Spain

Substances

Antineoplastic Agents, Immunological
Rituximab